Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation

被引：0
|
作者：
Christian Pfrepper
Anne Klink
Gerhard Behre
Thomas Schenk
Georg-Nikolaus Franke
Madlen Jentzsch
Sebastian Schwind
Haifa-Kathrin Al-Ali
Andreas Hochhaus
Dietger Niederwieser
Herbert Gottfried Sayer
机构：
[1] Universitätsklinikum Leipzig,Abteilung für Hämatologie, Internistische Onkologie
[2] Universitätsklinikum Jena,Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie
[3] HELIOS-Klinikum Erfurt,4. Medizinische Klinik (Hämatologie, internistische Onkologie und Hämostaseologie)
来源：
Journal of Cancer Research and Clinical Oncology | 2016年 / 142卷
关键词：
Allogeneic stem cell transplantation; Refractory acute myeloid leukemia; FLAMSA-RIC; Risk factors after allogeneic HCT, donor lymphocytic infusions; DLI; Reduced-intensity conditioning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：317 / 324
页数：7
相关论文
共 50 条
  • [31] Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia
    Dominik Schneidawind
    Birgit Federmann
    Christoph Faul
    Wichard Vogel
    Lothar Kanz
    Wolfgang Andreas Bethge
    Annals of Hematology, 2013, 92 : 1389 - 1395
  • [32] Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
    Haefaa Alchalby
    Nicolaus Kröger
    Current Hematologic Malignancy Reports, 2010, 5 : 53 - 61
  • [33] Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
    Alchalby, Haefaa
    Kroeger, Nicolaus
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (02) : 53 - 61
  • [34] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Anderlini, Paolo
    Saliba, Rima M.
    Ledesma, Celina
    Plair, Tamera
    Alousi, Amin M.
    Hosing, Chitra M.
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Hagemeister, Frederick B.
    Oki, Yasuhiro
    Neelapu, Saatva
    Romaguera, Jorge E.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1333 - 1337
  • [35] Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia
    Wilhelm, Christian
    Neubauer, Andreas
    Burchert, Andreas
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 2031 - 2035
  • [36] Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis
    Kroeger, N
    Zabelina, T
    Schieder, H
    Panse, J
    Ayuk, F
    Fehse, N
    Fehse, B
    Waschke, O
    Kvasnicka, HM
    Thiele, J
    Zander, A
    BLOOD, 2004, 104 (11) : 423A - 423A
  • [37] CLOFARABINE/ARA-C (CLARA) TREATMENT FOLLOWED BY REDUCED-INTENSITY CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK, RELAPSED, OR REFRACTORY ACUTE LEUKEMIA
    Buchholz, S.
    Krauter, J.
    Dammann, E.
    Ehrlich, S.
    Port, M.
    Weissinger, E.
    Stadler, M.
    Eder, M.
    Ganser, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 132 - 133
  • [38] Reduced-intensity conditioning with treosulfan and fludarabine prior to allogeneic stem cell transplantation in multiple myeloma patients
    Schmidt-Hieber, M
    Casper, J
    Trenschel, R
    Andreesen, R
    Einsele, H
    Kanz, L
    Fauser, A
    Uharek, L
    Thiel, E
    Blau, I
    BONE MARROW TRANSPLANTATION, 2006, 37 : S195 - S196
  • [39] Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan
    Yamashita, Takuya
    Takami, Akiyoshi
    Uchida, Naoyuki
    Fukuda, Takahiro
    Eto, Tetsuya
    Shiratori, Souichi
    Ota, Shuichi
    Akasaka, Takashi
    Miyakoshi, Shigesaburo
    Kondo, Tadakazu
    Hidaka, Michihiro
    Kanda, Junya
    Atsuta, Yoshiko
    Yano, Shingo
    BONE MARROW TRANSPLANTATION, 2020, 55 (10) : 1955 - 1965
  • [40] Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan
    Takuya Yamashita
    Akiyoshi Takami
    Naoyuki Uchida
    Takahiro Fukuda
    Tetsuya Eto
    Souichi Shiratori
    Shuichi Ota
    Takashi Akasaka
    Shigesaburo Miyakoshi
    Tadakazu Kondo
    Michihiro Hidaka
    Junya Kanda
    Yoshiko Atsuta
    Shingo Yano
    Bone Marrow Transplantation, 2020, 55 : 1955 - 1965
12345